Si-bone expands portfolio with the launch of new offering for the ifuse bedrock granite implant system and completes inaugural surgical procedures

Santa clara, calif., may 07, 2024 (globe newswire) -- si-bone, inc., (nasdaq: sibn), a silicon valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced the first cases completed with the smaller, 9.5 mm diameter, ifuse bedrock granite® implant (granite 9.5). when placed across the si joint, the granite implant provides sacroiliac fusion and spinopelvic fixation as a foundational element for multi-segment spinal fusion.
SIBN Ratings Summary
SIBN Quant Ranking